Chronic pain medication management of older populations

Key points from a national conference and innovative opportunities for pharmacy practice

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective: Inappropriate use of pain medication has serious consequences for older populations. Experts in the field have noted an increase in opioid prescriptions, and opioid-related hospitalisations and deaths among this vulnerable population. In the pursuit of educating pharmacists, physicians, allied healthcare professionals, researchers, academics and the public facing the challenges of chronic pain medication management, ‘The Inaugural Monash University School of Public Health and Preventive Medicine (SPHPM) Best Practice in Chronic Pain Medication Management Day Conference’ was held in December 2016 at the Alfred Medical Research and Education Precinct (Melbourne, Australia). Methods: Fifteen experts presented on aspects of chronic pain epidemiology and current analgesic use in older Australians, and discussed current practice and associated challenges. Results: Presenters highlighted the dramatic increase in opioid prescribing, development of tolerance and withdrawal symptoms, problems with abuse and addiction, increased risk of death from overdose or suicide, potentiation of sedative effects with concurrent use of anxiolytics/hypnotics, and medication diversion. Conclusions: Pharmacists are very accessible to patients and are crucial members of medication management teams. They have the necessary medication expertise to review medication regimens and provide patient education. Towards addressing chronic pain medication management of older populations, pharmacists can contribute in several ways, such as being aware of relevant guidelines and completing further training, contributing to policy and guideline development, participating in multidisciplinary panels, working groups and pain management teams, collaborating on research projects, and educating the community. With regards to opioid medication management, pharmacists are in an ideal position to: monitor prescription dispensing and potential misuse, provide education about overuse, and, if appropriate, provide access to naloxone. In order to fulfil these roles and responsibilities, allied healthcare professionals should be educated and informed, and opportunities for continuing professional education should be available and utilised. Pharmacists should have the necessary knowledge and skills to optimise chronic pain management, and to both deliver and inform policies and guidelines on pharmacological management of chronic pain in older people.

Original languageEnglish
Pages (from-to)207-213
Number of pages7
JournalResearch in Social and Administrative Pharmacy
Volume15
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • Analgesic
  • Chronic pain
  • Geriatrics
  • Medication
  • Prescribing

Cite this

@article{9ffe0654152e4513891c7878bdb02cfd,
title = "Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practice",
abstract = "Objective: Inappropriate use of pain medication has serious consequences for older populations. Experts in the field have noted an increase in opioid prescriptions, and opioid-related hospitalisations and deaths among this vulnerable population. In the pursuit of educating pharmacists, physicians, allied healthcare professionals, researchers, academics and the public facing the challenges of chronic pain medication management, ‘The Inaugural Monash University School of Public Health and Preventive Medicine (SPHPM) Best Practice in Chronic Pain Medication Management Day Conference’ was held in December 2016 at the Alfred Medical Research and Education Precinct (Melbourne, Australia). Methods: Fifteen experts presented on aspects of chronic pain epidemiology and current analgesic use in older Australians, and discussed current practice and associated challenges. Results: Presenters highlighted the dramatic increase in opioid prescribing, development of tolerance and withdrawal symptoms, problems with abuse and addiction, increased risk of death from overdose or suicide, potentiation of sedative effects with concurrent use of anxiolytics/hypnotics, and medication diversion. Conclusions: Pharmacists are very accessible to patients and are crucial members of medication management teams. They have the necessary medication expertise to review medication regimens and provide patient education. Towards addressing chronic pain medication management of older populations, pharmacists can contribute in several ways, such as being aware of relevant guidelines and completing further training, contributing to policy and guideline development, participating in multidisciplinary panels, working groups and pain management teams, collaborating on research projects, and educating the community. With regards to opioid medication management, pharmacists are in an ideal position to: monitor prescription dispensing and potential misuse, provide education about overuse, and, if appropriate, provide access to naloxone. In order to fulfil these roles and responsibilities, allied healthcare professionals should be educated and informed, and opportunities for continuing professional education should be available and utilised. Pharmacists should have the necessary knowledge and skills to optimise chronic pain management, and to both deliver and inform policies and guidelines on pharmacological management of chronic pain in older people.",
keywords = "Analgesic, Chronic pain, Geriatrics, Medication, Prescribing",
author = "Gilmartin-Thomas, {Julia Fiona-Maree} and Bell, {J. Simon} and Danny Liew and Arnold, {Carolyn A.} and Rachelle Buchbinder and Colin Chapman and Flavia Cicuttini and Malcolm Dobbin and Gibson, {Stephen J.} and Giummarra, {Melita J.} and Jenny Gowan and Benny Katz and Lubman, {Dan L.} and Matthew McCrone and Jennifer Pilgrim and Anneliese Synnot and {van Dyk}, Eleanor and Barbara Workman and John McNeil",
year = "2019",
month = "2",
doi = "10.1016/j.sapharm.2018.03.060",
language = "English",
volume = "15",
pages = "207--213",
journal = "Research in Social and Administrative Pharmacy",
issn = "1551-7411",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Chronic pain medication management of older populations

T2 - Key points from a national conference and innovative opportunities for pharmacy practice

AU - Gilmartin-Thomas, Julia Fiona-Maree

AU - Bell, J. Simon

AU - Liew, Danny

AU - Arnold, Carolyn A.

AU - Buchbinder, Rachelle

AU - Chapman, Colin

AU - Cicuttini, Flavia

AU - Dobbin, Malcolm

AU - Gibson, Stephen J.

AU - Giummarra, Melita J.

AU - Gowan, Jenny

AU - Katz, Benny

AU - Lubman, Dan L.

AU - McCrone, Matthew

AU - Pilgrim, Jennifer

AU - Synnot, Anneliese

AU - van Dyk, Eleanor

AU - Workman, Barbara

AU - McNeil, John

PY - 2019/2

Y1 - 2019/2

N2 - Objective: Inappropriate use of pain medication has serious consequences for older populations. Experts in the field have noted an increase in opioid prescriptions, and opioid-related hospitalisations and deaths among this vulnerable population. In the pursuit of educating pharmacists, physicians, allied healthcare professionals, researchers, academics and the public facing the challenges of chronic pain medication management, ‘The Inaugural Monash University School of Public Health and Preventive Medicine (SPHPM) Best Practice in Chronic Pain Medication Management Day Conference’ was held in December 2016 at the Alfred Medical Research and Education Precinct (Melbourne, Australia). Methods: Fifteen experts presented on aspects of chronic pain epidemiology and current analgesic use in older Australians, and discussed current practice and associated challenges. Results: Presenters highlighted the dramatic increase in opioid prescribing, development of tolerance and withdrawal symptoms, problems with abuse and addiction, increased risk of death from overdose or suicide, potentiation of sedative effects with concurrent use of anxiolytics/hypnotics, and medication diversion. Conclusions: Pharmacists are very accessible to patients and are crucial members of medication management teams. They have the necessary medication expertise to review medication regimens and provide patient education. Towards addressing chronic pain medication management of older populations, pharmacists can contribute in several ways, such as being aware of relevant guidelines and completing further training, contributing to policy and guideline development, participating in multidisciplinary panels, working groups and pain management teams, collaborating on research projects, and educating the community. With regards to opioid medication management, pharmacists are in an ideal position to: monitor prescription dispensing and potential misuse, provide education about overuse, and, if appropriate, provide access to naloxone. In order to fulfil these roles and responsibilities, allied healthcare professionals should be educated and informed, and opportunities for continuing professional education should be available and utilised. Pharmacists should have the necessary knowledge and skills to optimise chronic pain management, and to both deliver and inform policies and guidelines on pharmacological management of chronic pain in older people.

AB - Objective: Inappropriate use of pain medication has serious consequences for older populations. Experts in the field have noted an increase in opioid prescriptions, and opioid-related hospitalisations and deaths among this vulnerable population. In the pursuit of educating pharmacists, physicians, allied healthcare professionals, researchers, academics and the public facing the challenges of chronic pain medication management, ‘The Inaugural Monash University School of Public Health and Preventive Medicine (SPHPM) Best Practice in Chronic Pain Medication Management Day Conference’ was held in December 2016 at the Alfred Medical Research and Education Precinct (Melbourne, Australia). Methods: Fifteen experts presented on aspects of chronic pain epidemiology and current analgesic use in older Australians, and discussed current practice and associated challenges. Results: Presenters highlighted the dramatic increase in opioid prescribing, development of tolerance and withdrawal symptoms, problems with abuse and addiction, increased risk of death from overdose or suicide, potentiation of sedative effects with concurrent use of anxiolytics/hypnotics, and medication diversion. Conclusions: Pharmacists are very accessible to patients and are crucial members of medication management teams. They have the necessary medication expertise to review medication regimens and provide patient education. Towards addressing chronic pain medication management of older populations, pharmacists can contribute in several ways, such as being aware of relevant guidelines and completing further training, contributing to policy and guideline development, participating in multidisciplinary panels, working groups and pain management teams, collaborating on research projects, and educating the community. With regards to opioid medication management, pharmacists are in an ideal position to: monitor prescription dispensing and potential misuse, provide education about overuse, and, if appropriate, provide access to naloxone. In order to fulfil these roles and responsibilities, allied healthcare professionals should be educated and informed, and opportunities for continuing professional education should be available and utilised. Pharmacists should have the necessary knowledge and skills to optimise chronic pain management, and to both deliver and inform policies and guidelines on pharmacological management of chronic pain in older people.

KW - Analgesic

KW - Chronic pain

KW - Geriatrics

KW - Medication

KW - Prescribing

UR - http://www.scopus.com/inward/record.url?scp=85044788197&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2018.03.060

DO - 10.1016/j.sapharm.2018.03.060

M3 - Article

VL - 15

SP - 207

EP - 213

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1551-7411

IS - 2

ER -